FDA 483 - F2 Chemicals LTD - November 06, 2008

An FDA Form 483 was issued to F2 Chemicals LTD, an API (Active Pharmaceutical Ingredient) Producer located in Preston, Lancashire, U.K., on November 6, 2008, following an inspection by the U.S. Food and Drug Administration. This document detailed objectionable conditions observed during the inspection, highlighting areas of concern regarding the firm's quality control and manufacturing processes.

The primary observation related to the analytical method for assay and purity testing of stability study samples and finished products. The FDA noted that F2 Chemicals was not consistently utilizing a characterized reference standard, as stipulated in its original method. Instead, the firm's current testing method relied on a mixture prepared by an unaudited outside firm, raising questions about data integrity and product quality.

Secondly, the inspection revealed a significant gap in information concerning the cleaning of reused cylinders. F2 Chemicals lacked details about the cleaning or chemical agents used by the external company responsible for servicing these cylinders. This absence of critical information poses potential risks to product purity and safety from unknown contaminants.

As an FDA 483, this document serves as an official communication of inspectional observations. While not a final determination of compliance, it indicates that F2 Chemicals is expected to thoroughly investigate these issues and implement robust corrective and preventive actions to ensure adherence to good manufacturing practices and relevant regulatory requirements.